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Introduction
PABI is a large, muhicatalytic intracellular proteinase of about 700 kDa which was recently characterized [1] . When a small proteinasc inhibitor, such as Icupeptin. was added to the culture media of mammalian cells, the concentration of PABI increased 100 200-fold above the basal level. '[his unique accumulation was considered to be due to greatly reduced levels of degradation in the presence of such a proteinase inhibitor. PABI showed a rather complex substrate specificity, with obvious similarity tn that of trypsiv, and chymotrypsin, but not to those of plasmin, elastase or cyteine proteinases. PABI was a muhimer of a majttr subunit of 84 kDa and was not activated by NIP. '1 hese properties were unique to PABI and clearl~ different from several other known, large protcinascs [2] [3] [4] [5] [6] [7] [8] [9] . No specific biological role has yet been determined fur PABI. Proteosome. one of large multicatalytic proteinascs is apparently involved in ubiquitin-independent protein degradation. It may also be involved in other important functions, such as a stabilizing effect on mRNAs [10, 11] . Proteosome, 7700 kDa in size, is composed of multisubunits with a molecular ma.~s of 22 33 kDa. These proteinases arc constitutive components of cells and can be activated by polylysine, SDS. ATP or heparin. These proteinases, however, are not known to accumulate intracellularly L~ the presence of small protemase inhibitors. Recently, an ATP activated, high. molecular-weight proteinase isolated from muscle was reported to be a cysteine proteinase-tq-mac~oglobulin complex [121.
In thl~, paper, we de~,cribc the p~llllit.atild/ Oi ,1: i I~Aftl crnn,,-icacling matcri;tl from ph~,ma nmt ', I'e~ohlliOll election Inlt'lO'~cqipit ,lltal\c~a Ill !,h~l~3. Iil,ll PAIII i~ ilnc~,peuledI¥ a t'i~luplt '~, ill li qilacrl~b'h)bnhn. prilnilrll¥ ~ilh Ihrtlnlbin Wt. alsll itc~cribt, c~,l~c'l!nli'!lts ~lticli ~llo~ lh;il fi:q,llicrnghibtilhl anti thrnm' ,~ ,lie' iiitoflu~laletl nllo cultured ccll~ ,ind ~l.t;llil'lc>;Inlk d. unll~llC ill rhc prent'nce of leupeplin
Materials and Methods

M~terial.~
Purified human ,:-macroglobulin md liyp.siil 12 × cry,,lalline) were purchaned from Sigma (St. I.oui~,, MO). Purified bn'.dn¢ ~t,z-macroglobuhn ,,va,, l.)bldlnt'd from l:h,chringer-Mannheim IF.R(),). Goat ~mli-rabhii Ig(i conjugated wdh alkaline phosphai~v-e and prcstaincd SDS-PAG|i standards {phosphorylase B. bnvine serum ~llbumin, ovalbumin, carbonic anhydra,c, soybean Irvpsin inhibitor and lyso;,yme) were from Bio-Rad Ioaboralorit, s. Iluman thrombin {specific activity, 4.O5 N I H units/,agt ,rod anti-human prothrombin antibodies ~,cre kindly provided by I)r..lules A. Sharer at the Department of Biochemistry ~ff Ihis campus. The thrombin preparation contained a-lhromhin as the major c~m~pone~lt besides its nicked d:rivativcs (B-and ~-thrombin). Ne~born calf serum was from Whittaker Bioproducis (Walkcr~.',ille, MD). 4<hh)ro-l-n:tphthol was purchased from Sigma. The other reagents tised were of II1,; highest analytical grade available.
]'rt'pdr~ttto#l of dnll,~t rnnl dnd t#lrlnlrllohh)? alld!t':/, ~ Preparation of antiserum ~gainst purified PABI was prcviow, ly described II1. Immunoblot anab,~,is of pro. loin,, was cat tied out as fl~llows. Sodlunl dodecyl sulfi~te (~.l)S)-pol'~'acryl:mlide gel electrophoresis (PA(iE) was perforulcd by ihc utclhod of Laurel)[13 I. The proteins separated were then elccirophoretically transferred to the nitrocellulose pipe; at a setting of 30 V for 16 h according to the method of Towbin et al. [14! . lmmunodelection of PABI on nitrocellulose paper was carried out ~e-described previously [11. Protein coneerltr~ttlon wa~ dclermilted by tire ml!thod t)f Bradford l l~,]. Doable imnrunodiffuni,,nl an;.tly?,l~, wa,', performed aI na~n~ temperature using 19~ agarose in 50 mM phosphate-buffered saqne (PBS) (ptt 7.4), by the method of Ouchtcrlony 1161. After immunodiffusion, agamse gel wlls wa!,hed with PBS lind then :,rained with ('Onlrlassic brillianl blue R-250,
I'ur,]Tcat,nl g[ cro,ss-retwtmg proWin willi ant#PA BI
All puritication procedures were performed at 4o( . unh:ns ~d~crwise slated. Serum from newborn call' (I(X) rail ~a~ incubated widl poly(ethyleneglycol) (PI!G) 6l)(l() Ihe precipitate oblained with 4. I~% (w/v) PI!G cttlrce~ltrarlnn wz:s diss~ h'cd wilh 25 mM Tris-II('l (pll 7g) dialyzed ,lg,li:v,I the name buffer o~emighl and ,ipphcd Io a I)|;Al~-cclhdt;~,c column (2.()x 24 era), ~,iuihbr,dcd ~ith 25 mM l'lis-Fl('l (pH 7 5) . ihc colalnu ~as extensively ~ashed with Ihe same bulfer ~lnd cluted v, iih 1 I of a linear gradient buffe: solulion fl,l!rled of 0 ~md ft.4 M NaCI a! a flow rate of 6{) ml/h, lractitms ~,t 6 ml were collected a:ltl wure ~l~sayed by iummm~hlnt anah~,is, f, ractions containing irrlnrtln,Dreact~wty were pooled, concentrated by ultracentrifugation (18700 × g, 20 h in a Beckman centrifuge) ~nd the pellet was dissolved in 25 mM Tris-HCI {pl-I 7.5) and applied t~ a hydroxy apatite column (2.0 × 18 cm) equilibrated with 25 mM "[ris-HCI (pH 7.5). ]'he colun,n was extcnsivek' was',,ed with the same buffer and elutcd wi~h a linear gradient of 0 Io 0,3 M sotliunl phosphate (pH 7. ~< !he inlmuuoreactivc fraction~, were eunceniratcd by ullrafiltralion (Am)con, XM-II)O filter) and applied to a Sepharcryl S-300 (superfine) column 12.0 x q3 cml equilibrated with 25 mM Tris-I-Itl (pH 7,5) containing I}.15 M NaCI. "[he column was eluted with the same buffer at a flow rate of 15 ml/h Fractions of 2,0 ml were collected and the immunoreaetive fractions were pooled and concentr~t.'d by ultrafiltralion.
('ell ddture
BtlK cells were cultured in Eat~le's minimum essential media flqEM) (Gibco) supplemented with streptomycin, penicillin and 1{)9,~ fetal calf serum in a 5~, CO, incubatur at 37'~C.
II~llmololih~l dlllll|'.~is
hnnlunohlol analysis was carried out as previously described 11] with minor modifications. Cell extracts (7.5 itg as protein), media (7.5/Lg as protein) or purified human a-thmmbin (25 ltg) were dissolved in gel loading bufler (62.5 mM Tris-HCI (pH 6.8, containing 10~, glycerol. 2% SDS and 10f";~ /bmercaptoeihanol) and heated at IO0°C for 5 min, The samples were then subjected to SDS-polyacrytamide t;el (12%) electrophoresis employing ~ mini-gel apparatus tBio-Radl. Prestained protein si:~ndards were used as size markers. 'lhc clectrophoresed proteins were transferred to a nitrocellulose filter [141 . The blotted filters were incubated with 3~, gelatin in 50 mM Tris-HCI {pH 7,5) containing 0.15 M NaCI (TBS) at 37°C for 3t) rain. The filters were then incubated with the anti-PABI antiserum [11 at 1:500 dilution, followed by incubation with goal anii-r.'lbbil Ig,G conjugated with horseradish peroxidase according to manufacturer's instructions. The filter bk'~te'~ with human thrombin was incubated with partially purified rabbit antibodies, anii-PAB! antibodies or r~tbbrt anti-human prothrombin antibodies at a 1: 101)() dilution, following the procedures described above. The filters were then incubated with '[BS conraining 4-chloro-l-naptho, I ({).5 mg/ml) for 3(I min at PABI depleted serum ,,',as prepared ,,s fulhw.s. Ft'lal calf serum (2.5 mh was added with a half volume of anli-PABI serum and incubated at 37"¢" f,~ .~ t, followed by continued incubation al 4°C overnight. The serum was then centrifuged at 3500 rpm for 15 rain. fne supernatant obtained was used as a,-macroglobulindepleted FCS. Bttl;. cells grown to near confluency in 10 cm dishes were briefly treated with 2 ml or 0.25~,', (~,,,'w) trypsin in I0 mM sodium pht~r phale/saline buffer (pll "~.4| (PBS buffer) clu'~taining 0.5 mM EDTA. After discardin G the ,rypsin solution, fresh PBS h~ffer (2 ml) wan ,~dded to harvest the cells. BHK cells were plated in 6 em dishes at about 15~ confluenc~ in cult;~red in 3.0 ml MI£M with and without 6(i flg/ml leupeptin, supplemended either with 11) lOe;, FCS only, ~2) lOq~ PABI-depleled FCS or {3t I0~ PABl-depleted FCS containing 0.75 mg bovine %-macroglobulin. (?ells were grown for 48 h to about 80~ confluency and harvested by scraping after washing cells three times with 10 .~M sodium phosphate saline (pH 7.4). The harvested cells v.ere briefly centrifugeo and stored as a pellet at 20~C until use. In a separate experiment. BHK cells ",,ere grown for 48 h in media with and without leupeptin supplemented with, (I) 10~, PABI-depleled FCS preincubated with 0.75 mg a,-macroglobulin for 30 rain at a~om temperature or (2) I0~t~ PABI-depleted FCS preincubated with 0.75 mg a:-macroglohulin and 0.09 mg thrombin fo~' 30 rain at room temperature.
For immuaoblot analysis, the frozen pellets were thav,,ed and vigorously mixed by vortexing with 0.2 ml of ice-cold 20 mM Tris-ttCI (ptl 7.5) containing 1 mM eatl:. The hornogenale was Ihen centrifuged at 12IILIt) rpm for 2 rain and the supcrnatants obtained were used as cell extract for Western blot analysis. An aliquot (15 ~tl) of media diluted with the loading buffer to give the final protein concentration of 05 ttg/ml wa~, also subjetted to Western blot analysis. with three pe~ks from sephac~'l S-300 with immunoblot analysis of elution fractions, The front peak which contains the major band of at3ut 180000 was observed as cross-reacting material. A ?ew minor bands o, lower molecular weights were also observed. The anti-PABl cross-reactivity material fAPCRM) was purified to more than 95% homogeneity (Fig. 4) . About 60 ~.,~ of the purified APCRM was obtained from lflO ml of newborn calf serum. The )ield was estimated to be about 30%
The purified APCRM was then tested for its identity with plasma a2-macroglobulin. Cross-reactivity of anti-PABI with purified bovine a2-macroglobulin is shown in Fig. 1 (right panel) . The precipitine line clearly fused with that of purified APCRM (wells 4 and 5) strongly suggesting the identity of APCRM with bovine ~2-mac~oglobulin. The precipitine line of purified human a: macroglobulin fused neither with that of purified bovine az-macroglobulin nor with that of APCRM in calf plasma. When the purified APCRM and the purified bovine a2-macroglobulin were digested with try, psin. essentially identical fragmemed peptide patterns were observed (Fig. 4) . These results ir~dicate that the major component of PAB! is bovine a:-macroglobulin. but not other proteins such as at-macroglobulin and pregnancy zone protein.
Etectron microscopic analysis of PA BI
Results of electron microscopic analysis and computer image analysis are shown in Fig. 5 . Panel A shows the electron microscopic image (side view) of PABI. Computer image ~nalysis revealed the H shaped structure of PABi. This structure was found to be highly similar to the basic model determined for tetrameric human a:-macroglobulin complexed with either chymotrypsin, trypsin or thrombin which was described as a padlock shape, H shape or cyrillic character shape [20 23 ]. The ninety degree rotated image (end view) was also very similar to that of human a2-macroglobulinchymotrypsin complex previously reporte~l [22] . Because the shape of the a2-macroglobulin molecule is unique, these observations strongly suggest that PABI is identical to a complex of tetrameric a,-maeroglobulin and a proteinase(s).
hnmunoblot attalvsis of PA BI
The results of immunoblot analysis of human thrombir ith anti-PABl antibody as well as anti-prothrombin antibody are shown in Fig. 6 . In this immunoblot analysis, both anti-PABl and anti-prothrombin detected the B-chain of human a-thrombin (33 kDa band in this gel) and its nicked derivatives (bands o'. about 13, 22 and 19 kDa) [24] . A-chain of a-thrombin (62 amino acid residues in lenglh) ran out of the gel and is not shown in this picture. These results strongly suggest that at least one type of the proteinases complexed with a~-macroglobulin in PAB! is thrombin. Antiplasmin failed to cross-react with PABI (data not shown), agreeing with the previous observation that PAB! does not have plasmin-like ~ub~trate specificity [ll. Other proteinases with chymotryps~n-like substrate the cL,-macroglobulin concentration in the media (lanes 1 and 2). a_,-Maeroglobulin-depleted serum showed only a trace amount of t~:-macroglobulin in the media (lanes 4 and 5 of Fig. 7) . while the media supplemented with purified bovine a:macroglobulin again shows a,-macroghtbulin bands (lanes 6 and 7) as intense as in lanes 1 and 2. These results indicate that the amounl of anti-PABl antibodies employed to deplete serum mmacroglobulin is just enough to deplete the endogenous serum a,:macrogtobulin, and not in excess to further hind the supplemented purified a:macroglobulin. Baml (" in lanes 4, 5. 6 and 7 in Fig. 7 correspond'~ te a fragment derived from rabbit anti-PABI IgGs added to the media in order to deplete serum az-macroglob"tin. When intracellular PABI was analyzed ( much higher levels (lanes 2, 4 and 6 in Fig, 8 ) compared to the trace amount of band e. if any. in the presence of leupeptin (lane 3 and 7). Band d v, as also considered to be an intracellular degradation product of PABI. These results show that bovine a:-macroglobulin in the media is internalized by BHK cells followed by efficient intracellular degradation in the absence of leupeptin, but significant protection from degradation in the presence of leupeptin resulting in its great accumulation in cells.
As shown in Fig, 9 . anti-prothrombin antibodies recognized greatly increa~d intracellular thrombin in the presence of leupeptin (bands a and d in lane 4). only when both a:-macrog!obulin and thrombin ~ere a,Jt;.:d to the PABI-depleted calf serum. The increase was not observed when the serum was supplemented only with a~-macroglobulin. These results indicate that the formation of the complex (PABI) between a:-macroglobulin and lhrombin is a prerequisite for internalization and subsequent intracellular accumulation of PABI in the presence of leupeptin (Fig. 9) . The results also suggests that free and active thrombin is essentially absent in the PABl-depleted serum (lane 2 of Fig. 9 ). Thrombin in serum might have been consumed not only by forming PABI complex and complexe,, v~;th otl'~er prolcinase inhibitors such a', antithrombie II1. but ab,~ b', degradations. When anI~-PABI antibodies ~cre used hi place of anti-prothrombiu in this experiment. ;m increased amount of intracellular PABI. :rod its protection from degradatic, n in the presence of leupeptin v, erc observed as expected (data not shownt+ These results show that at least one of the prt,-teinases complexed with u_.-macroglobulin ia PABI i', throtnbin in the serum which is added to the culture media.
Di,ieussion
PABI '.','as originally identified as a large, multicttalyric proteinase that is greatb ele,,ated in its intracellular concentration primari b in the ly~osomat fraction in the presence of small proteinase inhibitors, such as leupeFtin [1] . In order to determine its biological role. PAB! was further characterized in the present stud,,.
We first carried out electron microscopic anabsi~ of PABi to compare with the tertiary structures previously reported for other large proteinases [25] . The electron microseopic image obtained for PABI ~as unexpectedl,, very similar to those of tetrameric a_,-macroglobulin eomplexed v, ith proteinases, such as chymotrypsin and trypsin (Fig. 5) [ 21 23 ]. The resut; slrongiy suggested that PABI was a complex of az-macroglobulin and a proteinase(sl+ which was internalized by the cul:ured t:elis, presumably by the receptor ,uediated endocytosis [26] [27] [28] . ]'he result also pros(des further evidence that the H shaped electron microscop+c image is of the a.-macroglobulin comole,;ed 'aith a protcinase00, but not of" the native form of a:-macroglobulin as previously postulated [29] .
Tests for immunological cro,,:,-reactivit? (Fig~,. I and 2) show that anti-PABI cro~,s-reacting material (APCRM) i~, also present in sera. and that APCRM forms fused precipitine lines onl', v, ith box(he a,-macroglobulin, Furthermore. other properties of the purified APCRM. such as tryptic peptide map also agree ',','ell with those of u_,-macroglobulin. The~,e results, dearly indicate that the major component of PABI is ~,erum a,-macroglobulin and not other proteins including its homologous proteins, such as acmacroglobulin ~,r pregnancy zone protein {12.30].
The proteiua~s complexed v.ith a.-macroglobulin in PABI include those v, hich have t~'psin-like or chymotrypsin-like specifictty, but neither cxsteine proteinase. etastase nor phtsmin-like proteinase~, as previously observed ll], This suggests that intracellular proteinases (particularly lysosomal proteinases) pr~uced b: the cells are apparently not complexed ~,ith a,-macroglobulin in PABI. These ob~rvations ate consistent ,xith the well estabtished fact that the cell receptor Becaw, e svnthctlc ,,uh,,trate~,. such as CBZ,Arg-MCA. Z-Phe-Arg-MCA and BCt'-VaI-I-eu-L3'z-MCA ,aere ',ers poor snbstratcs for P~BI I1]. the proteinase in PABI ',,.as considered not to be tr~psiu. The majetr?,psin-like substrate specificity of PABI. however, was rathel simi!ar to thai of thrombiu [1] . Therefore. we speculated that thrombin is a possible proteinase component of PABI. In immunoblot analysis, both anti-prothromhin antiht~y and anti-PABl antibody recognized ~-thrombin and ils derivatives by staining identical hands in Western blot analysis (Fig. 6 ). This indicates that thrombin present in the supplemented serum is one of the major proteinases complcxed ~ith a,-macroglobulin in PABI. Results of a series of PABI uptake o;periments (Fig~, , (7) (8) (9) clearly show that leupeptin, transported to the lysosomes of the cells [1] . protected PABI molecules from proteolytic degradation, reauhing in high a~_cumulalions of PABI in the cells. Furthermore. the results of PABI-depletion and protein supplemcntation experiments {Fig. 9) show that lhrombin complexcd ~ith %-macroglobulin can be taken up by cells, agreeing well with the previous observations [26 -28] . A proleinase(s) with chymotrypsin-like substratc specificity is also contained in some PABI molecules [1] . The intrinsic chymotrypsin-like activity of thrombin ma3, be responsible for this activity [35] [36] [37] [38] . At the presenl, however, no definitive identity of the proteinasc[s) is available. Major proteinases '~hich arc complexed wiOt rr:-macroglobulin in PABI are apparently restricted m a few protemases, such as thrombin, probabb due to their availability as active proteinases in serum. This may furthcr suggest that the intracellular accumulation of PABI observed in the present experiments is a phenomenon only relevant to the cultured cells x~hich are exposed to the media containing a:-macroglobulin complexed with activated protcinascs such as thmmbin.
Wc have also observed that cultured ral capillary endt.thelial cells can elevate their PABI concentration to a very high level in the presence of leupeptin (unpublished data). These results may further suggest that a,-macroglobulin apparently functions as an internalizalion vehicle for thrombin and some other specific proteinases in the plasma not only for the clearance of those proteinases from the plasma, but also for bringing those proteinases to their potential, alternative function site in cells. Recently. az-macroglnbulin bindings were reported for interleukin-1/:/[391, basic fibroblast growth factor [40] as well as for transforming growth factors [41, 42] . These observations further suggest an important function of %-macroglobulin as a general carrier pro_ lein for helerologous, but specific proteins in the plasma. Tanaka el al.
[45] previously reported isolation of an acidic thiol proteinase induced in rat liver by the intraperitoneal[y administered leupeptin. Interestingly. when leupeptin was injected into peritoneal cavity of rats in our pre!.minary study, a significant increase in the intensity of an immunostained band of about 90 kDa, which corresponds to PABI. was observed in the liver as well as in the kidney (unpublished data). This observation suggests a significant accumulation of PABI in vivo mav also take place when leupeptin is given to the animals. The proteinase(s) component of the PABI in "d',x'~ is to be determined. The observations made in the presen, study are also important for better understanding of the in vivn mechanism of aclion of small peptide proteinase inhibilors which are given to patients for muscle dystrophy treatment or in other pathological conditions 146-48].
